Every bear market since 2001 has only ended with a plethora of insider buying. I’m waiting, waiting, and waiting without any insider buying to speak of. There is not much selling either. Just keep in mind that bear markets don’t go straight down. Who’s saying we are in one anyway? Maybe it’s just a slow-motion train wreck that every earnings webcast is riddled with uncertainty and lowered earnings expectations.
Name: Joseph P. Adams Jr.
Position: CEO and Chairman
Transaction Date: 05-02-2025 Shares Bought: 3,000 shares an Average Price Paid of $94.54 for Cost: $283,620
Name: David Moreno
Position: Chief Operating Officer
Transaction Date: 05-02-2025 Shares Bought: 6,580 shares an Average Price Paid of $94.85 for Cost: $624,113
Company: FTAI Aviation Ltd. (FTAI):
FTAI Aviation Ltd., a Cayman Islands-exempt corporation, leases and sells aviation equipment. The company also develops and manufactures aftermarket components for aircraft engines through a joint venture and oversees repairs and distribution through maintenance facilities and exclusivity agreements. FTAI Aviation focuses on assets that generate strong cash flows and offer opportunities for profit growth and asset appreciation. Leveraging industry expertise, strategic relationships, and capital access, the company is positioned to pursue acquisition opportunities within the aviation sector.
Joseph P. Adams Jr. has served as Chief Executive Officer of FTAI Aviation Ltd. since May 2015 and as Chairman of the Board since May 2016. Prior to joining FTAI Aviation, he was a Managing Director at Fortress Investment Group’s Private Equity Group and served on its Management Committee. He previously held roles at Brera Capital Partners and Donaldson, Lufkin & Jenrette, focusing on the transportation sector. In 2002, he was appointed the first Executive Director of the Air Transportation Stabilization Board. Mr. Adams holds a Bachelor of Science in Engineering from the University of Cincinnati and an MBA from Harvard Business School.
David Moreno has served as Chief Operating Officer of FTAI Aviation Ltd. since January 2021. Prior to this role, he was part of the Private Equity Group at Fortress Investment Group from 2013 to 2021, where he focused primarily on aviation-related investments. Mr. Moreno holds a Bachelor of Arts in Business Administration and a Master of Science in Accounting from Babson College.
Opinion: FTAI sold off on a large revenue miss on Q1. Fly on the Wall comments RBC Capital lowered the firm’s price target on FTAI Aviation to $130 from $140 and keeps an Outperform rating on the shares. The firm cites the company’s Q1 EPS and revenue miss, the analyst tells investors in a research note. RBC adds however that while it can appreciate the potential investor concerns on the quality of the EBITDA beat, lingering uncertainties on SCI, or Strategic Capital Initiative, and continuous cash flow invested into the business, FTAI’s Aerospace Products results were robust, with upside from SCI and PMA still in play.
Name: Samit Hirawat
Position: EVP,Chief Med.Offr.,Drug Dev.
Transaction Date: 04-25-2025 Shares Bought: 4,250 shares an Average Price Paid of $47.58 for Cost: $202,215
Company: Bristol Myers Squibb Co (BMY):
Bristol-Myers Squibb Company was incorporated in Delaware in August 1933 as a successor to a New York corporation established in 1887. The company was renamed Bristol-Myers Squibb Company following a merger in 1989. It operates within a single business segment focused on the global discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. Its strategy integrates the scale and resources of a pharmaceutical company with the speed and innovation typical of the biotechnology sector. The company concentrates on developing transformational medicines for patients with serious diseases, particularly in oncology, hematology, neuroscience, and other therapeutic areas that offer potential for significant clinical impact and shareholder value.
Dr. Samit Hirawat serves as Executive Vice President, Chief Medical Officer, and Head of Development at Bristol Myers Squibb. He joined the company in 2019. In this role, he oversees early- and late-stage product development across all therapeutic areas, with an emphasis on accelerating asset progression from proof-of-concept to commercialization through advanced clinical trial design and operations. Dr. Hirawat earned his Bachelor of Medicine and Bachelor of Surgery degrees from Sawai Man Singh Medical College in India and completed his internal medicine residency and medical oncology training at North Shore University Hospital in New York.
Opinion: BMY hasn’t been a very good investment for a very long time. It’s encouraging to see insider buying from its Chief Medical Development officer but its way too little and too few buying in.
Name: Glenn W. Stetson
Position: EVP-Production
Transaction Date: 03-14-2025 Shares Bought: 500 shares an Average Price Paid of $47.49 for Cost: $23,745
Transaction Date: 04-28-2025 Shares Bought: 1,000 shares an Average Price Paid of $41.53 for Cost: $41,530
Name: Joseph Wm. Foran
Position: Chairman and CEO
Transaction Date: 04-29-2025 Shares Bought: 5,000 shares an Average Price Paid of $40.86 for Cost: $204,300
Company: Matador Resources Co (MTDR):
Matador Resources Company is an independent energy firm engaged in the acquisition, exploration, development, and production of oil and natural gas resources in the United States. It operates through two segments: exploration and production, and midstream. The company’s primary operations are focused in the Wolfcamp and Bone Spring plays in the Delaware Basin of Southeast New Mexico and West Texas. It also manages assets in the Eagle Ford shale formation in South Texas and the Haynesville shale and Cotton Valley fields in northwest Louisiana. Natural gas is sold to unaffiliated independent marketing companies and midstream operators. Originally named Matador Holdco, Inc., the company was renamed Matador Resources Company in August 2011. It was founded in 2003 and is headquartered in Dallas, Texas.
Mr. Stetson joined Matador Resources Company in August 2014 as a Production Engineer and was promoted to Asset Manager in July 2015. He was named Vice President and Asset Manager in July 2018, followed by a promotion to Senior Vice President of Production and Asset Manager in October 2019. In March 2022, he joined the company’s financial planning team to support the Chief Financial Officer and finance department. He was subsequently promoted to Executive Vice President of Production in April 2022. Mr. Stetson holds a Bachelor of Science degree in Mechanical Engineering Technology from Oklahoma State University and is a licensed Professional Engineer in the state of Oklahoma.
Mr. Stetson joined Matador Resources Company in August 2014 as a Production Engineer and was promoted to Asset Manager in July 2015. He was named Vice President and Asset Manager in July 2018, followed by a promotion to Senior Vice President of Production and Asset Manager in October 2019. In March 2022, he became part of the financial planning team, supporting the Chief Financial Officer and finance department. He was promoted to Executive Vice President of Production in April 2022. Mr. Stetson holds a Bachelor of Science degree in Mechanical Engineering Technology from Oklahoma State University and is a licensed Professional Engineer in the state of Oklahoma.
Joseph Wm. Foran founded Matador Resources Company in July 2003 and has served as its Chairman and Chief Executive Officer since its inception. Prior to establishing Matador Resources, he led Matador Petroleum Corporation from 1988 until its sale in June 2003. Mr. Foran began his career in the oil and gas industry in 1983 as a co-founder of Foran Oil Company. He holds a Bachelor of Science in Accounting with highest honors from the University of Kentucky and a Juris Doctor degree from the Southern Methodist University Dedman School of Law, where he was a Hatton W. Sumners Scholar and served as the Leading Articles Editor of the Southwestern Law Review.
Opinion: With E&P producers down across the board, I’d stay with the service companies. You need to produce more when you’re getting paid less for each barrel of oil. Matador is about 59% oil and 41% natural gas according to Grok. Natural gas has been a much better performer recently.
Name: John R. Haley
Position: Director
Transaction Date: 05-02-2025 Shares Bought: 2,246 shares an Average Price Paid of $44.57 for Cost: $100,100
Name: R. Howard Coker
Position: President & CEO
Transaction Date: 05-01-2025 Shares Bought: 20,000 shares an Average Price Paid of $41.17 for Cost: $823,472
Company: Sonoco Products Co (SON):
Sonoco Products Company, founded in Hartsville, South Carolina, in 1899 as the Southern Novelty Company, began by producing cone-shaped paper yarn carriers. The company quickly became a leading U.S. manufacturer of paper cones and expanded its product lines nationally. Today, Sonoco focuses on sustainable packaging solutions designed to support brand identity, improve product quality, and enhance consumer experiences by delivering customized, innovative packaging aligned with customer goals.
John R. Haley has served as a director of Sonoco Products Company since 2011 and was appointed Chairman of the Board in 2019. He is also the Chief Executive Officer of Gosiger, Inc., a privately held distributor of computer-controlled machine tools and factory automation systems, a position he has held since 2010. Mr. Haley holds a bachelor’s degree from the University of Notre Dame and an MBA from the University of Virginia.
R. Howard Coker has served as President and Chief Executive Officer of Sonoco Products Company since 2020. He began his career with the company in 1985, holding roles in sales, manufacturing, and management across its consumer and industrial businesses. Prior to his current role, Mr. Coker held several senior leadership positions, including Senior Vice President of Global Paper and Industrial Converted Products, and Senior Vice President of Rigid Paper Containers and Paper/Engineered Carriers International, where he oversaw operations across North America, South America, Europe, and Asia. He holds a Bachelor of Arts in Business Administration from Wofford College and an MBA from Wake Forest University.
Opinion: The acquisition of Eviosys, a European metal packaging company, for $3.9 billion in 2024, expanded Sonoco’s global footprint and is expected to generate significant synergies. Long term investors have suffered greatly for the stock’s poor performance. CEO Coker has bought ~$2.8 million worth of stock this year. Maybe it’s time for a bump
Name: Pierre R. Breber
Position: Director
Transaction Date: 04-29-2025 Shares Bought: 10,000 shares an Average Price Paid of $26.89 for Cost: $268,877
Name: David P. Hess
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 7,500 shares an Average Price Paid of $26.52 for Cost: $198,900
Company: Southwest Airlines Co (LUV):
Southwest Airlines Co. is a passenger airline that provides scheduled air service across the United States and select international markets. As of December 31, 2024, the airline operated a fleet of 803 Boeing 737 aircraft, serving 117 destinations in 42 states, the District of Columbia, the Commonwealth of Puerto Rico, and ten near-international countries, including Mexico, Jamaica, the Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. The airline offers in-flight entertainment, internet services, and a loyalty program, Rapid Rewards, which allows customers to earn points based on dollars spent on base fares. Southwest Airlines Co. was founded in 1967 and is headquartered in Dallas, Texas.
Pierre R. Breber joined the Board of Directors of Southwest Airlines Co. in November 2024. He brings extensive financial and operational expertise from his tenure at Chevron Corporation, where he served as Vice President and Chief Financial Officer from April 2019 to February 2024. His prior roles included Executive Vice President of Downstream and Chemicals and Executive Vice President of Gas and Midstream. Mr. Breber holds bachelor’s and master’s degrees in mechanical engineering from the University of California, Berkeley, and an MBA from Cornell University.
David P. Hess has been a Director on the Board of Southwest Airlines Co. since November 18, 2021. He brings significant leadership experience in aerospace and the military, having held executive positions at United Technologies Corporation, including President of Pratt & Whitney and President of Hamilton Sundstrand. Mr. Hess holds a Bachelor’s degree in Physics from Hamilton College, a Bachelor’s and Master’s degree in Electrical Engineering from Rensselaer Polytechnic Institute, and a Master of Management from the MIT Sloan School of Management.
Opinion: There have been a few insiders buying at Southwest, the largest buy from a director that owns the largest airline in India. That was about $100 million worth of stock, much more than the former CFO of Chevron is willing to commit.
Name: John T. Thomas
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 4,200 shares an Average Price Paid of $17.84 for Cost: $74,928
Name: Ava Lias-Booker
Position: Director
Transaction Date: 04-29-2025 Shares Bought: 5,000 shares an Average Price Paid of $17.83 for Cost: $89,150
Name: Scott M. Brinker
Position: President and CEO
Transaction Date: 04-28-2025 Shares Bought: 11,337 shares an Average Price Paid of $17.68 for Cost: $200,438
Name: Sara Grootwassink Lewis
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 6,000 shares an Average Price Paid of $17.66 for Cost: $105,938
Name: Katherine M. Sandstrom
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 11,288 shares an Average Price Paid of $17.65 for Cost: $199,233
Company: Healthpeak Properties Inc. (DOC):
Healthpeak Properties, Inc., a Standard & Poor’s 500 company, is a real estate investment trust that owns, operates, and develops high-quality healthcare-related properties across the United States. Founded in 1985, the company underwent a corporate restructuring in 2023 to become an umbrella partnership REIT. Headquartered in Denver, Colorado, it also maintains offices in California, Tennessee, Wisconsin, and Massachusetts. The company’s diversified portfolio spans three primary asset classes: outpatient medical, lab, and continuing care retirement community (CCRC) real estate. It focuses on the ownership, operation, and development of outpatient medical centers, hospitals, and laboratory facilities. In the CCRC segment, properties are operated under RIDEA structures.
John T. Thomas served as President, Chief Executive Officer, and Trustee of Healthpeak Properties, Inc. from 2013 until its merger with Physicians Realty Trust. He has held the position of Vice Chair of the Board since March 2024. Prior to his tenure at Healthpeak, he held executive roles at Welltower Inc. and Cirrus Health, and served as Senior Vice President and General Counsel at Baylor Health Care System. Mr. Thomas earned a Juris Doctor from Vanderbilt University Law School and a Bachelor of Science from Jacksonville State University.
Ava E. Lias-Booker joined the Board of Directors of Healthpeak Properties, Inc. in March 2024, following the company’s merger with Physicians Realty Trust, where she had served as a trustee since 2022. She has over 30 years of experience in complex commercial and civil litigation and currently leads the Baltimore litigation group at McGuireWoods LLP, where she has been a partner since 2004. She also serves on the visiting boards of Duke University School of Law and the University of Maryland Francis King Carey School of Law. Ms. Lias-Booker earned her Juris Doctor from the University of Maryland Francis King Carey School of Law.
Mr. Brinker has served as President and Chief Executive Officer since October 2022 and as a member of the Board of Directors since that time. He previously held the roles of President and Chief Investment Officer from January 2019 to October 2022, and Executive Vice President and Chief Investment Officer from March 2018 to December 2019. Prior to joining the company, Mr. Brinker spent over 15 years at a healthcare real estate investment trust, where he held various investment and portfolio management roles, most recently serving as Executive Vice President and Chief Investment Officer. Mr. Brinker holds a Bachelor of Arts from Yale University and a Master’s degree from the Ross School of Business at the University of Michigan.
Ms. Sandstrom was appointed Chair of the Board in April 2023, after serving as Vice Chair from April 2022 to April 2023. She served as an Advisor from July 2018 to March 2019 and was previously Senior Managing Director and Global Head of the Public Real Estate Securities division at Heitman LLC from 2013 to 2018. Since joining Heitman in 1996, Ms. Sandstrom held several senior leadership roles across the institutional real estate investment sector and was a member of the firm’s Global Management Committee, Board of Managers, and Allocation Committee. She is a certified public accountant and holds a Bachelor of Arts in Accounting from the University of West Florida.
Pamela J. Shelley-Kessler joined the Board of Directors in March 2024, following the merger with Physicians Realty Trust, where she had served as an independent trustee since January 2018. She is Co-Chief Executive Officer and Co-President of LTC Properties Inc., a role assumed on December 31, 2024, after serving as the company’s Chief Financial Officer since 2010. Ms. Shelley-Kessler began her career as a certified public accountant at Ernst & Young and has held leadership roles across multiple real estate and healthcare organizations. She earned her undergraduate degree from the University of California, Irvine.
Opinion: Lots of small buys may indicate broad consensus that the stock is reasonably, perhaps bargain priced with its 7% dividend yield.
Name: Jerry M. Bauer
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 20,000 shares an Average Price Paid of $12.88 for Cost: $257,660
Company: Marten Transport Ltd (MRTN):
Marten Transport Ltd has strategically evolved from a refrigerated long-haul carrier into a diversified transportation company offering time- and temperature-sensitive as well as dry truck-based transportation and distribution services across six core business platforms: Temperature-Sensitive Truckload, Dry Truckload, Dedicated, and MRTN de Mexico. It is recognized as a leading temperature-sensitive truckload carrier in the United States, specializing in the transportation and distribution of food and other consumer packaged goods that require controlled or insulated environments. Marten Transport operates in the United States, Mexico, and Canada, with the majority of its revenue generated in the United States. The company provides regional truckload services across the Southeast, West Coast, Midwest, South Central, and Northeast regions.
Jerry M. Bauer has served as a Director of Marten Transport Ltd. since January 1997. He is the Chairman and Chief Executive Officer of Bauer Built, Inc., a company specializing in the distribution of new and retreaded tires and petroleum products across the Midwest, a position he has held since 1976. Mr. Bauer brings extensive expertise in the tire and petroleum industries, contributing valuable insight to Marten Transport’s transportation operations. He holds an undergraduate degree from the University of Wisconsin Business School.
Opinion: Trucking and transportation stocks have been eviscerated. Things seem so bad, they must be bottoming here.
Name: Jonathan M. Peacock
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 8,091 shares an Average Price Paid of $12.81 for Cost: $103,646
Name: Lan Kang
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 5,000 shares an Average Price Paid of $12.57 for Cost: $62,850
Name: Gregory L. Summe
Position: Director
Transaction Date: 04-28-2025 Shares Bought: 25,000 shares an Average Price Paid of $12.50 for Cost: $312,500
Name: Joseph R. Massaro
Position: Director
Transaction Date: 04-29-2025 Shares Bought: 8,100 shares an Average Price Paid of $12.30 for Cost: $99,630
Company: Avantor Inc. (AVTR):
Avantor, Inc. provides mission-critical products and services to customers in the biopharma, healthcare, education, government, advanced technologies, and applied materials industries across the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. Founded in 1904, the company is headquartered in Radnor, Pennsylvania.
Mr. Peacock has served as Chairman since 2022 and has been a member of the Board since 2017. He is also a member of the Nomination and Governance Committee. Additionally, Mr. Peacock chairs the Board of Directors at UCB SA. He previously served as Chief Financial Officer of Amgen, Inc. from 2010 to 2014 and as Chief Financial and Administrative Officer of Novartis AG’s Pharmaceuticals Division from 2005 to 2010. Mr. Peacock holds a master’s degree in economics from the University of St. Andrews in Scotland and is a chartered accountant.
Ms. Kang has been on the Board since April 2021 and is currently a member of the Compensation & Human Resources Committee. She has served as President and CEO of Azkarra Therapeutics, an early-stage biotechnology company, since March 2025. Ms. Kang previously held several executive positions at Fosun International, a global consumer-focused corporation listed on the Hong Kong Stock Exchange, including Executive Board Director, Head of the Fosun Insurance Group, and Chief Human Resources Officer of Fosun Group. She holds an MBA in healthcare administration from the Wharton School at the University of Pennsylvania, a master’s degree in chemistry from Tulane University, and a bachelor’s degree in biological science and technology from Zhejiang University in Hangzhou, China.
Mr. Summe has been a member of the Board since May 2020, where he chairs the Nominating and Governance Committee and serves on the Compensation and Human Resources Committees. He is the Managing Partner at Glen Capital Partners, an investment fund. Mr. Summe also serves on the boards of State Street Corporation, NXP Semiconductors NV, and Wheels Up. He previously served as Managing Director and Vice Chairman of Global Buyouts at The Carlyle Group, as well as a Senior Advisor to Goldman Sachs Capital Partners. Mr. Summe holds an MBA with distinction from The Wharton School at the University of Pennsylvania, a master’s degree in electrical engineering from the University of Cincinnati, and a bachelor’s degree in electrical engineering from the University of Kentucky. He is a member of the Hall of Distinction at the University of Kentucky.
Mr. Massaro has been a member of the Board since 2021 and currently serves as Chair of the Audit and Finance Committee. He is Aptiv PLC’s Chief Financial Officer and Senior Vice President of Business Operations, a position he has held since September 2016. Previously, Mr. Massaro held several senior management positions at Aptiv, including Vice President and Corporate Controller. He also served as Chief Financial Officer at inVentiv Health and Managing Director at Liberty Lane. Mr. Massaro holds an MBA and a Master of Science in Accounting from Northeastern University and a Bachelor of Science in Finance and Economics from Bentley University.
Opinion: The entire biotech market and medical science industry feels like its entering the modern-day equivalent of the Dark Ages. I hear that in not so many words but listening to the earnings webcasts of health care REITs like HealthPeak Properties, DOC.
Follow us on Twitter for real-time commentary and insider buying alerts at https://twitter.com/theinsidersfund
If you are a QUALIFIED INVESTOR and are interested in learning how you can be part of the Insiders Fund, schedule some time with me here.
This blog is solely for educational purposes and the author’s own amusement. IT IS NOT INVESTMENT ADVICE. Think of the blog as part of my personal investment journal that I am willing to share with the DIY investor. There are also many parts that I am not willing to share if I think it could influence trading action or be detrimental to the Fund’s partners. We could be long, short, or have no position at all in any of the stocks mentioned and express no written or implied obligation to disclose any of that.
The Insiders Fund and its blogs and posts are not affiliated with, endorsed by, or sponsored by any of the companies mentioned herein. All company names, logos, and trademarks belong to their respective owners. The use of company logos is solely for descriptive and illustrative purposes under fair use. Any information provided is based on publicly available data and should not be considered financial, investment, or legal advice. Readers should conduct their own research or consult with a professional before making any investment decisions.
Insiders sell the stock for many reasons, but they generally buy for just one – to make money. You’ve always heard the best information is inside information. Everyone with any stock market experience pays close attention to what insiders are doing. After all, who knows a business better than the people running it? Officers, directors, and 10% owners are required to inform the public through a Form 4 Filing of any transaction, buy, sell, exercise, or any other within 48 hours of doing so. This info is available for free from the SEC’s Web site, Edgar, although we subscribe to SECForm4 as they provide a way to manage and make sense of the vast realms of data. I’ve tried a lot of vendors. SECForm4 is one of the smaller ones, but I like supporting Frank. He is not arrogant. He’s helpful and has great prices. He also trades on his own data, so I like people that eat what they kill.
The bar is different from selling because the natural state of management is to be a seller. This is because most companies provide significant amounts of management compensation packages as stock and options. Therefore, we analyze unusual patterns with selling, such as insiders selling 25 percent or more of their holdings or multiple insiders selling near 52-week lows. Another red flag is large planned sale programs that start without warning. Unfortunately, the public information disclosure requirements about these programs, referred to as Rule 10b5-1, are horrendously poor. Also, planned sales that pop up out of nowhere are basically sales and are seeking cover under this corporate welfare loophole. I also generally ignore 10 percent shareholders as they tend to be OPM (other people’s money) and perhaps not the smart money on which we are trying to read the tea leaves. I say generally because some 10% shareholders are great investors. Think Warren Buffett and others
Of course, insiders can also be wrong about their Company’s prospects. Don’t let anyone fool you into believing they never make mistakes. Do your own analysis. They can easily be wrong, and in many cases, maybe most cases, have no more idea what the future may hold than you or me. In short, you can lose money following them. We have, and we curse aloud; what were they thinking!
We like Fly on the Wall for keeping up with what events might be happening, analysts’ comments, and whatever else could be moving the stock. Dow Jones news service is an essential tool, but many services pick up their feed like they do Bloomberg. For quick financial analysis, it’s hard to beat Old School Value.
A big callout to my assistant Ambreen who sets up this conversation by listing the notable buys that I’ve identified as soon as practically possible. She probes the 10k for a reasonable description of the business. I’ve found that to be the most accurate and succinct place to find out what a business actually does. When I have time, over the weekend, I’ll add some preliminary analysis to the Opinion at the end. Sometimes I won’t update this for a couple of weeks or more. A good way to use this blog is as I do, it’s a reference point and filing cabinet for various stocks with notable insider buying. It’s one of many tools I use. I regularly live on Chat GPT and Microsoft Copilot now. I find the footnotes research very helpful in eliminating errors from AI hallucinations.
The Insiders Fund is for qualified investors and by Prospectus only. Nothing herein should be construed otherwise. THE INSIDERS FUND prefers to invest in companies at or near prices that management has been willing to invest significant amounts of their own money in, but we have no requirement to do so. We also invest in many companies in anticipation of future insider buying or with the expectation that there is none at all.
You can be an insider, too– by clicking here
Prosperous Trading,
